Abiopharma

News list

Freeman Chris 🟢 acquired 18.7K shares (1 derivative) of Guardant Health, Inc. (GH) Transaction Date: Mar 11, 2026 | Filing ID: 000004

Full text

News bot March 14, 2026, 12:34 a.m.
🔍 Freeman Chris (Executive)

Company: Guardant Health, Inc. (GH)

Report Date: 2026-03-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 18,744
Detailed Transactions and Holdings:
- Acquired 18,744 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,744.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- F2: Not applicable for Restricted Stock Units.